相关实验视频

Updated: Jun 10, 2025

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

智能变体过 - 一个蓝图解决方案,用于基于大量并行测序的变体分析

Orlinda Brahimllari^1,2, Sandra Eloranta³, Patrik Georgii-Hemming⁴

¹MedTechLabs, BioClinicum, Karolinska University Hospital, Stockholm, Sweden.

Health informatics journal

|October 11, 2024

概括

这项研究设计了一个人工智能增强系统,通过系统地过和解释通过大规模并行测序识别的遗传变异来简化淋巴瘤的临床诊断.

科学领域:

基因组学就是基因组学.
生物信息学是一种生物信息学.
人工智能的人工智能

背景情况:

大规模并行测序为癌症患者生成复杂的基因组数据.
用于临床决策的遗传变体的手动解释是劳动密集型的.
准确识别可操作的变体对于癌症诊断至关重要.

研究的目的:

设计一种系统解决方案,用于在淋巴瘤临床诊断中进行变异过和解释.
利用人工智能提高基因组数据分析的效率.

主要方法:

进行了对变异过解决方案的范围审查.
演示和与临床专家的采访为解决方案蓝图提供了信息.
机器学习方法被纳入诊断决策过程.

主要成果:

开发了一个人工智能增强基因诊断系统的蓝图.
该系统集成了算法,AI应用程序,软件和生物信息学管道.
验证采访证实了蓝图在各专业学科的相关性.

结论:

一个人工智能增强系统旨在预测淋巴瘤的致病变体.
该系统有助于分类变种,但人类监督对于准确性至关重要.
诊断人员必须验证AI分类,并做出最终的致病变体确定.

关键词:

人工智能是一种人工智能.临床决策临床决策机器学习是机器学习.大规模并行测序.这是下一代测序.变体分析变体分析变种过器的过方式

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

相关概念视频

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....